Walleye Capital
TYRA icon

Walleye Capital’s Tyra Biosciences TYRA Stock Holding History

Walleye Capital’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1M Buy
347,898
+329,183
+1,759% +$10.9M 0.04% 430
2026
Q1 		$717K Buy
+18,715
New +$606K ﹤0.01% 2371
2025
Q4 		– Sell
-297,808
Closed -$4.17M – 5162
2025
Q3 		$4.17M Sell
297,808
-72,600
-20% -$828K 0.02% 1041
2025
Q2 		$3.54M Buy
370,408
+229,666
+163% +$2.18M 0.01% 1104
2025
Q1 		$1.31M Buy
140,742
+77,762
+123% +$1.01M 0.01% 1757
2024
Q4 		$875K Sell
62,980
-63,617
-50% -$1.15M ﹤0.01% 2496
2024
Q3 		$2.98M Buy
126,597
+95,451
+306% +$2M 0.01% 1592
2024
Q2 		$498K Buy
31,146
+14,259
+84% +$245K ﹤0.01% 3522
2024
Q1 		$277K Buy
+16,887
New +$277K ﹤0.01% 3721

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Walleye Capital's TYRA Position: Q2 2026 in Review

Walleye Capital increased its Tyra Biosciences (TYRA) stake by 1,759% in Q2 2026, buying an estimated $10.9M and bringing the position to 347,898 shares worth $11.1M. The position accounts for 0.04% of the portfolio, ranked #430.

Walleye Capital first reported a position in TYRA in Q1 2024 and has held it in 9 quarters since. 169 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Walleye Capital held 347,898 shares of Tyra Biosciences worth $11.1M as of Q2 2026.
  • Walleye Capital bought 329,183 Tyra Biosciences shares in Q2 2026, an estimated $10.9M.
  • Tyra Biosciences made up 0.04% of Walleye Capital's portfolio in Q2 2026, its #430 holding.
  • Walleye Capital first reported a position in Tyra Biosciences in Q1 2024 and has held it in 9 quarters since.
  • 169 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.